Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

被引:410
作者
Hillion, J
Canals, M
Torvinen, M
Casadó, V
Scott, R
Terasmaa, A
Hansson, A
Watson, S
Olah, ME
Mallol, J
Canela, EI
Zoli, M
Agnati, LF
Ibáñez, CF
Lluis, C
Franco, R
Ferré, S
Fuxe, K
机构
[1] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden
[2] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain
[3] Univ Michigan, Mental Hlth Inst, Ann Arbor, MI 48109 USA
[4] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[5] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy
[6] NIDA, Baltimore, MD 21224 USA
关键词
D O I
10.1074/jbc.M107731200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antagonistic and reciprocal interactions are known to exist between adenosine and dopamine receptors in the striatum. In the present study, double immunofluorescence experiments with confocal laser microscopy showed a high degree of colocalization of adenosine A A receptors (A(2A)R) and dopamine D-2 receptors (D2R) in cell membranes of SH-SY5Y human neuroblastoma cells stably transfected with human D2R and in cultured striatal cells. A(2A)R/D2R heteromeric complexes were demonstrated in coimmunoprecipitation experiments in membrane preparations from D2R-transfected SH-SY5Y cells and from mouse fibroblast Ltk(-) cells stably transfected with human D2R (long form) and transiently cotransfected with the A(2A)R double-tagged with hemagglutinin. Long term exposure to A(2A)R and D2R agonists in D2R-cotransfected SH-SY5Y cells resulted in coaggregation, cointernalization and codesensitization of A(2A)R and D2R. These results give a molecular basis for adenosine-dopamine antagonism at the membrane level and have implications for treatment of Parkinson's disease and schizophrenia, in which D2R are involved.
引用
收藏
页码:18091 / 18097
页数:7
相关论文
共 35 条
[1]   A NEW APPROACH TO QUANTITATE THE DENSITY AND ANTIGEN CONTENTS OF HIGH-DENSITIES OF TRANSMITTER-IDENTIFIED TERMINALS - IMMUNO-CYTOCHEMICAL STUDIES ON DIFFERENT TYPES OF TYROSINE-HYDROXYLASE IMMUNOREACTIVE NERVE-TERMINALS IN NUCLEUS CAUDATUS PUTAMEN OF THE RAT [J].
AGNATI, LF ;
FUXE, K ;
ZINI, I ;
CALZA, L ;
BENFENATI, F ;
ZOLI, M ;
HOKFELT, T ;
GOLDSTEIN, M .
NEUROSCIENCE LETTERS, 1982, 32 (03) :253-258
[2]  
Akhondzadeh S, 2000, J CLIN PHARM THER, V25, P131
[3]   Dopaminergic transmission in the rat retina: Evidence for volume transmission [J].
Bjelke, B ;
Goldstein, M ;
Tinner, B ;
Andersson, C ;
Sesack, SR ;
Steinbusch, HWM ;
Lew, JY ;
He, X ;
Watson, S ;
Tengroth, B ;
Fuxe, K .
JOURNAL OF CHEMICAL NEUROANATOMY, 1996, 12 (01) :37-50
[4]   Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism [J].
Chase, TN ;
Oh, JD .
TRENDS IN NEUROSCIENCES, 2000, 23 (10) :S86-S91
[5]   Immunological identification of A(1) adenosine receptors in brain cortex [J].
Ciruela, F ;
Casado, V ;
Mallol, J ;
Canela, EI ;
Lluis, C ;
Franco, R .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 42 (06) :818-828
[6]   Adenosine A(2A) receptors modulate the binding characteristics of dopamine D-2 receptors in stably cotransfected fibroblast cells [J].
Dasgupta, S ;
Ferre, S ;
Kull, B ;
Hedlund, PB ;
Finnman, UB ;
Ahlberg, S ;
Arenas, E ;
Fredholm, BB ;
Fuxe, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 316 (2-3) :325-331
[7]  
DUNCAN OD, 1977, MATH DEMOGRAPHY, P349
[8]   Cross-sensitization between the motor activating effects of bromocriptine and caffeine:: role of adenosine A2A receptors [J].
Fenu, S ;
Cauli, O ;
Morelli, M .
BEHAVIOURAL BRAIN RESEARCH, 2000, 114 (1-2) :97-105
[9]   Dopamine D-1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopeduncular pathway and its modulation by adenosine A(1) receptor-mediated mechanisms [J].
Ferre, S ;
OConnor, WT ;
Svenningsson, P ;
Bjorklund, L ;
Lindberg, J ;
Tinner, B ;
Stromberg, I ;
Goldstein, M ;
Ogren, SO ;
Ungerstedt, U ;
Fredholm, BB ;
Fuxe, K .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (07) :1545-1553
[10]   Adenosine-dopamine interactions in the ventral striatum - Implications for the treatment of schizophrenia [J].
Ferre, S .
PSYCHOPHARMACOLOGY, 1997, 133 (02) :107-120